The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, highlight the growing interest in mental health treatment.Read More

You might also be interested in reading Crypto Fear and Greed Index Shows Market Sentiment Remains Fearful.